| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 ADGRL1 OR8H1 OR2T2 GPRC6A OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 5.66e-10 | 884 | 68 | 18 | GO:0004930 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 1.97e-09 | 431 | 68 | 13 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 PKD1 GPR141 ADGRL1 GRIA2 OR8H1 OR2T2 GPRC6A OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 1.29e-08 | 1353 | 68 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.11e-05 | 343 | 68 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 2.97e-05 | 18 | 68 | 3 | GO:0004016 | |
| GeneOntologyMolecularFunction | cyclase activity | 7.26e-05 | 24 | 68 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 8.23e-05 | 25 | 68 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.14e-04 | 5 | 68 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.62e-04 | 459 | 68 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.77e-04 | 465 | 68 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.93e-04 | 171 | 68 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | channel activity | 4.01e-04 | 525 | 68 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.02e-04 | 664 | 68 | 9 | GO:0008324 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.06e-04 | 526 | 68 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 6.16e-04 | 11 | 68 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 7.38e-04 | 12 | 68 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | sodium channel activity | 7.41e-04 | 52 | 68 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | odorant binding | 9.28e-04 | 127 | 68 | 4 | GO:0005549 | |
| GeneOntologyMolecularFunction | sodium ion binding | 1.01e-03 | 14 | 68 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.27e-03 | 627 | 68 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 1.33e-03 | 16 | 68 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.42e-03 | 793 | 68 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.52e-03 | 26 | 68 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 3.52e-03 | 26 | 68 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 4.12e-03 | 758 | 68 | 8 | GO:0015318 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2T8 OR8H2 ADCY10 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 ADGRL1 OR8H1 OR2T2 GPRC6A TRPM1 OR6C65 OR2T12 ZDHHC3 PTGFR PTGIR ADCY3 OR2AE1 ADCY8 OR6K6 | 4.34e-11 | 1395 | 68 | 23 | GO:0007186 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 2.93e-10 | 465 | 68 | 14 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2T8 OR8H2 OR14K1 OR2K2 PIEZO2 OR2T33 OR2T35 SCN1A OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 5.34e-10 | 582 | 68 | 15 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2T8 OR8H2 OR14K1 OR2K2 PIEZO2 OR2T33 OR2T35 SCN1A OR6C74 PKD1 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 1.16e-09 | 722 | 68 | 16 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 1.38e-09 | 432 | 68 | 13 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 2.39e-09 | 547 | 68 | 14 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 5.53e-09 | 485 | 68 | 13 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 1.39e-08 | 524 | 68 | 13 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception | OR2T8 OR8H2 OR14K1 OR2K2 PIEZO2 OR2T33 OR2T35 SCN1A OR6C74 OR8H1 OR2T2 TRPM1 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 4.73e-08 | 1072 | 68 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 5.55e-06 | 11 | 68 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 3.96e-05 | 191 | 68 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 5.79e-05 | 23 | 68 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 7.48e-05 | 25 | 68 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.59e-04 | 286 | 68 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 4.12e-04 | 44 | 68 | 3 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 4.40e-04 | 45 | 68 | 3 | GO:0009187 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 5.31e-04 | 113 | 68 | 4 | GO:0051262 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 5.33e-04 | 48 | 68 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 5.33e-04 | 48 | 68 | 3 | GO:1902656 | |
| MousePheno | abnormal chemical nociception | 1.38e-05 | 44 | 47 | 4 | MP:0002735 | |
| Domain | Olfact_rcpt | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 OR2AE1 OR6K6 | 1.18e-09 | 393 | 67 | 13 | IPR000725 |
| Domain | 7tm_1 | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 OR8H1 OR2T2 OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 1.50e-09 | 677 | 67 | 16 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 OR8H1 OR2T2 OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 1.77e-09 | 685 | 67 | 16 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 OR8H1 OR2T2 OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 2.01e-09 | 691 | 67 | 16 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 OR8H1 OR2T2 OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 2.05e-09 | 692 | 67 | 16 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR2T8 OR8H2 OR2K2 OR2T33 OR2T35 OR6C74 GPR141 OR8H1 OR2T2 OR6C65 OR2T12 PTGFR PTGIR OR2AE1 OR6K6 | 1.10e-08 | 670 | 67 | 15 | IPR017452 |
| Domain | Nucleotide_cyclase | 3.46e-05 | 18 | 67 | 3 | IPR029787 | |
| Domain | - | 3.46e-05 | 18 | 67 | 3 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 4.10e-05 | 19 | 67 | 3 | PS00452 | |
| Domain | Guanylate_cyc | 4.10e-05 | 19 | 67 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 4.10e-05 | 19 | 67 | 3 | PS50125 | |
| Domain | A/G_cyclase | 4.10e-05 | 19 | 67 | 3 | IPR001054 | |
| Domain | CYCc | 4.10e-05 | 19 | 67 | 3 | SM00044 | |
| Domain | - | 7.57e-05 | 4 | 67 | 2 | 3.90.1460.10 | |
| Domain | GTF2I | 7.57e-05 | 4 | 67 | 2 | PS51139 | |
| Domain | GTF2I | 7.57e-05 | 4 | 67 | 2 | PF02946 | |
| Domain | GTF2I | 7.57e-05 | 4 | 67 | 2 | IPR004212 | |
| Domain | Thbox_rcpt | 1.26e-04 | 5 | 67 | 2 | IPR001105 | |
| Domain | Na_trans_cytopl | 1.88e-04 | 6 | 67 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 1.88e-04 | 6 | 67 | 2 | IPR024583 | |
| Domain | ARM-type_fold | 2.08e-04 | 339 | 67 | 7 | IPR016024 | |
| Domain | Prostanoid_rcpt | 3.50e-04 | 8 | 67 | 2 | IPR008365 | |
| Domain | AC_N | 3.50e-04 | 8 | 67 | 2 | IPR032628 | |
| Domain | Adcy | 3.50e-04 | 8 | 67 | 2 | IPR030672 | |
| Domain | AC_N | 3.50e-04 | 8 | 67 | 2 | PF16214 | |
| Domain | Na_channel_asu | 5.60e-04 | 10 | 67 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 5.60e-04 | 10 | 67 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 5.60e-04 | 10 | 67 | 2 | PF06512 | |
| Domain | Ion_trans_dom | 7.50e-04 | 114 | 67 | 4 | IPR005821 | |
| Domain | Ion_trans | 7.50e-04 | 114 | 67 | 4 | PF00520 | |
| Domain | A/G_cyclase_CS | 1.67e-03 | 17 | 67 | 2 | IPR018297 | |
| Domain | GPS | 6.60e-03 | 34 | 67 | 2 | SM00303 | |
| Domain | GPS | 6.99e-03 | 35 | 67 | 2 | PF01825 | |
| Domain | GPS | 7.38e-03 | 36 | 67 | 2 | PS50221 | |
| Domain | GPS | 7.79e-03 | 37 | 67 | 2 | IPR000203 | |
| Domain | ANF_lig-bd_rcpt | 7.79e-03 | 37 | 67 | 2 | IPR001828 | |
| Domain | ANF_receptor | 7.79e-03 | 37 | 67 | 2 | PF01094 | |
| Domain | Peripla_BP_I | 8.62e-03 | 39 | 67 | 2 | IPR028082 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 2.66e-10 | 417 | 53 | 14 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR2T8 OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 SCN3A OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 7.02e-09 | 636 | 53 | 15 | M41834 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR2T8 OR8H2 OR2K2 OR2T33 OR6C74 OR8H1 OR2T2 OR6C65 OR2T12 ADCY3 OR2AE1 OR6K6 | 1.58e-08 | 389 | 53 | 12 | M14091 |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.71e-05 | 16 | 53 | 3 | M39849 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 4.91e-04 | 9 | 53 | 2 | MM15014 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 4.91e-04 | 9 | 53 | 2 | M804 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.12e-04 | 10 | 53 | 2 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 6.12e-04 | 10 | 53 | 2 | MM14668 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 6.80e-04 | 46 | 53 | 3 | M39828 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 1.15e-03 | 55 | 53 | 3 | M39763 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 1.23e-03 | 14 | 53 | 2 | MM15012 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.23e-03 | 14 | 53 | 2 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.23e-03 | 14 | 53 | 2 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M56 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 1.41e-03 | 15 | 53 | 2 | M10620 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.41e-03 | 15 | 53 | 2 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 1.61e-03 | 16 | 53 | 2 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.61e-03 | 16 | 53 | 2 | MM14492 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.82e-03 | 17 | 53 | 2 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.82e-03 | 17 | 53 | 2 | M47544 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 2.04e-03 | 18 | 53 | 2 | MM15858 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 2.28e-03 | 19 | 53 | 2 | M48238 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 2.28e-03 | 19 | 53 | 2 | M39728 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 2.52e-03 | 20 | 53 | 2 | MM1529 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.52e-03 | 20 | 53 | 2 | M759 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 3.05e-03 | 22 | 53 | 2 | M22003 | |
| Pubmed | OR2T8 OR8H2 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR6C65 OR2T12 OR6K6 | 1.55e-09 | 343 | 69 | 10 | 32295537 | |
| Pubmed | OR2T8 OR8H2 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR6C65 OR2T12 OR6K6 | 1.69e-09 | 346 | 69 | 10 | 14611657 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 2.48e-08 | 340 | 69 | 9 | 11875048 | |
| Pubmed | 2.48e-08 | 340 | 69 | 9 | 11802173 | ||
| Pubmed | OR8H2 OR14K1 OR2K2 OR2T33 OR2T35 OR6C74 OR8H1 OR2T2 OR2T12 OR6K6 | 1.14e-07 | 541 | 69 | 10 | 14983052 | |
| Pubmed | 1.22e-06 | 11 | 69 | 3 | 10808179 | ||
| Pubmed | 2.17e-06 | 46 | 69 | 4 | 32126975 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 2.68e-06 | 14 | 69 | 3 | 14993377 | |
| Pubmed | Signaling pathways for modulation of mouse sperm motility by adenosine and catecholamine agonists. | 3.88e-06 | 2 | 69 | 2 | 16291925 | |
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 3.88e-06 | 2 | 69 | 2 | 24990319 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 27690330 | ||
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 3.88e-06 | 2 | 69 | 2 | 15388857 | |
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 3.88e-06 | 2 | 69 | 2 | 23965409 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 12610651 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 33895391 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 23859570 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 17586501 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 18784617 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 17544618 | ||
| Pubmed | A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. | 1.16e-05 | 3 | 69 | 2 | 8476432 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 27816501 | ||
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 15100712 | ||
| Pubmed | Soluble adenylyl cyclase activity is necessary for retinal ganglion cell survival and axon growth. | 1.16e-05 | 3 | 69 | 2 | 22649251 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 14973256 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 17537961 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 35031483 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 29578003 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 18938093 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 17823943 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 23229069 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 22899722 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 21328569 | ||
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 35801810 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 2.32e-05 | 4 | 69 | 2 | 8974318 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 1679748 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 8812438 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 16129400 | ||
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 16807365 | ||
| Pubmed | MicroRNAs regulate renal tubule maturation through modulation of Pkd1. | 3.86e-05 | 5 | 69 | 2 | 23138483 | |
| Pubmed | 3.86e-05 | 5 | 69 | 2 | 24337656 | ||
| Pubmed | Mechanoreceptor synapses in the brainstem shape the central representation of touch. | 5.79e-05 | 6 | 69 | 2 | 34637701 | |
| Pubmed | Chromosomal localization of the human prostanoid receptor gene family. | 5.79e-05 | 6 | 69 | 2 | 7759114 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 17462990 | ||
| Pubmed | Tulp3 Is a Ciliary Trafficking Gene that Regulates Polycystic Kidney Disease. | 5.79e-05 | 6 | 69 | 2 | 30799240 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 5.79e-05 | 6 | 69 | 2 | 23652591 | |
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 15983244 | ||
| Pubmed | 8.09e-05 | 7 | 69 | 2 | 12613887 | ||
| Pubmed | Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. | 1.08e-04 | 8 | 69 | 2 | 15834430 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 11927615 | ||
| Pubmed | Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. | 1.08e-04 | 8 | 69 | 2 | 17496729 | |
| Pubmed | Prostanoid receptors: structures, properties, and functions. | 1.08e-04 | 8 | 69 | 2 | 10508233 | |
| Pubmed | Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. | 1.08e-04 | 8 | 69 | 2 | 20566843 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 19966781 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 1.38e-04 | 9 | 69 | 2 | 9417641 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 21460251 | ||
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 12503609 | ||
| Pubmed | Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. | 1.38e-04 | 9 | 69 | 2 | 11782353 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 16382098 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 1.38e-04 | 9 | 69 | 2 | 17229090 | |
| Pubmed | 1.38e-04 | 9 | 69 | 2 | 15746173 | ||
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 1.73e-04 | 10 | 69 | 2 | 8663304 | |
| Pubmed | 1.73e-04 | 10 | 69 | 2 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 1.73e-04 | 10 | 69 | 2 | 11884542 | |
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 11299302 | ||
| Pubmed | 2.11e-04 | 11 | 69 | 2 | 10089566 | ||
| Pubmed | Genome-wide association study of body mass index in 23 000 individuals with and without asthma. | 2.11e-04 | 11 | 69 | 2 | 23517042 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 8169823 | ||
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 23518926 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 2.53e-04 | 12 | 69 | 2 | 30175250 | |
| Pubmed | 2.53e-04 | 12 | 69 | 2 | 10807185 | ||
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 15123669 | ||
| Pubmed | 3.41e-04 | 469 | 69 | 6 | 27634302 | ||
| Pubmed | Enhancer interaction networks as a means for singular olfactory receptor expression. | 3.48e-04 | 14 | 69 | 2 | 25417106 | |
| Pubmed | 4.01e-04 | 15 | 69 | 2 | 7937899 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 4.01e-04 | 15 | 69 | 2 | 2165385 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 4.01e-04 | 15 | 69 | 2 | 9726281 | |
| Pubmed | 4.57e-04 | 16 | 69 | 2 | 17567809 | ||
| Pubmed | Heterochromatin-mediated gene silencing facilitates the diversification of olfactory neurons. | 4.57e-04 | 16 | 69 | 2 | 25437545 | |
| Pubmed | Olfactory receptors and signalling elements in the Grueneberg ganglion. | 5.18e-04 | 17 | 69 | 2 | 16805845 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.39e-04 | 736 | 69 | 7 | 29676528 | |
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 6.49e-04 | 19 | 69 | 2 | 30228200 | |
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 7.20e-04 | 20 | 69 | 2 | 17082620 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.93e-04 | 208 | 69 | 4 | 33230847 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 8.51e-04 | 212 | 69 | 4 | 33853758 | |
| Pubmed | 1.04e-03 | 24 | 69 | 2 | 24152035 | ||
| Pubmed | Mapping of the genes encoding mouse prostaglandin D, E, and F and prostacyclin receptors. | 1.04e-03 | 24 | 69 | 2 | 8833158 | |
| Pubmed | Tubby family proteins are adapters for ciliary trafficking of integral membrane proteins. | 1.13e-03 | 25 | 69 | 2 | 28154160 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 1.18e-03 | 1061 | 69 | 8 | 33845483 | |
| Pubmed | 1.32e-03 | 27 | 69 | 2 | 23624557 | ||
| Pubmed | Modulation of the combinatorial code of odorant receptor response patterns in odorant mixtures. | 1.32e-03 | 27 | 69 | 2 | 32061665 | |
| Pubmed | 1.52e-03 | 29 | 69 | 2 | 28344592 | ||
| Pubmed | 1.74e-03 | 31 | 69 | 2 | 12626323 | ||
| Pubmed | 1.84e-03 | 650 | 69 | 6 | 38777146 | ||
| Pubmed | 1.85e-03 | 32 | 69 | 2 | 19542561 | ||
| Pubmed | 1.97e-03 | 33 | 69 | 2 | 39002541 | ||
| Pubmed | 1.97e-03 | 33 | 69 | 2 | 19834762 | ||
| Interaction | OR2T12 interactions | 9.01e-06 | 2 | 61 | 2 | int:OR2T12 | |
| Cytoband | 1q44 | 1.75e-08 | 110 | 69 | 6 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 4.33e-08 | 128 | 69 | 6 | chr1q44 | |
| GeneFamily | Olfactory receptors, family 2 | 3.28e-08 | 113 | 52 | 7 | 149 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.65e-06 | 10 | 52 | 3 | 53 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 2.88e-04 | 9 | 52 | 2 | 207 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.88e-04 | 9 | 52 | 2 | 1203 | |
| GeneFamily | Olfactory receptors, family 6 | 4.24e-04 | 51 | 52 | 3 | 153 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 1.43e-05 | 199 | 69 | 6 | M8082 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.99e-06 | 234 | 57 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.30e-05 | 195 | 69 | 5 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-05 | 198 | 69 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 69 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.67e-05 | 150 | 69 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 9.13e-05 | 152 | 69 | 4 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-05 | 152 | 69 | 4 | aff7d1127ef72be489477611c4decc53cc7632e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Platelets|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-05 | 152 | 69 | 4 | 0a99c91165e4d82fb8825fbdf3071c9a5445669d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 154 | 69 | 4 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 154 | 69 | 4 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 154 | 69 | 4 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 1.03e-04 | 157 | 69 | 4 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-04 | 159 | 69 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.17e-04 | 162 | 69 | 4 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | Immune_cells-B_cell|World / Lineage and Cell class | 1.19e-04 | 163 | 69 | 4 | 3a02465de7c2f7cea227e289fb082a1fb6400301 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 167 | 69 | 4 | 8ce8d93c79ac6a3f52252b4cec53378c362bfe0a | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 167 | 69 | 4 | 8340f7075d00dccb304cfd4c9b5711ca6dbf7cce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 167 | 69 | 4 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.34e-04 | 168 | 69 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.34e-04 | 168 | 69 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | -SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.40e-04 | 170 | 69 | 4 | 601630644f09133ee4c5e64499460b55cf3e80a0 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.40e-04 | 170 | 69 | 4 | 53e9372cb06a2dc5c8ecb3f9af42f3c23da96431 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 171 | 69 | 4 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 171 | 69 | 4 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 171 | 69 | 4 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-04 | 171 | 69 | 4 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | a31c23406cf6d6a17358a8fb41d392a7fb0306e0 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 171 | 69 | 4 | 43d8fd9b9546e84a652564fe96b514b34b06262b | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 173 | 69 | 4 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 173 | 69 | 4 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 175 | 69 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 175 | 69 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 175 | 69 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.64e-04 | 177 | 69 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-04 | 177 | 69 | 4 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 1.64e-04 | 177 | 69 | 4 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 177 | 69 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 178 | 69 | 4 | 499640cfb1063aa40343ec1563e40fe4645466fb | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.68e-04 | 178 | 69 | 4 | 851fdcf1451880a048885cc6677b4edfff6aee4c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.68e-04 | 178 | 69 | 4 | 1a3b3b73e81ceb26cec8153cd1bdd7b446887a71 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_memory-B_memory-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 179 | 69 | 4 | fce1ba53815145f6248d4e90aedca3dad84e33e4 | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.79e-04 | 181 | 69 | 4 | 700adfb41e4e377530f0dd31be89e12f109f3469 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.82e-04 | 182 | 69 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 182 | 69 | 4 | d524ad5cf00f05ee27c9db2ffa2d4e30a1e2e21a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.82e-04 | 182 | 69 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | B_cells-ABCs|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.86e-04 | 183 | 69 | 4 | bf9c6fe3ce4e44e4056027257eab8448c39c4fb8 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 1.86e-04 | 183 | 69 | 4 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 1.86e-04 | 183 | 69 | 4 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.90e-04 | 184 | 69 | 4 | 5bb775253a10a14360b06a46aba46d162a9bd1f8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | CTRL-Lymphoid|CTRL / Disease state, Lineage and Cell class | 1.90e-04 | 184 | 69 | 4 | 26fb2c4e6cb9950c27eb15428e7e74e5abb4397d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-04 | 184 | 69 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-04 | 184 | 69 | 4 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.90e-04 | 184 | 69 | 4 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.90e-04 | 184 | 69 | 4 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.94e-04 | 185 | 69 | 4 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 3'_v3-blood-Lymphocytic_B|blood / Manually curated celltypes from each tissue | 1.98e-04 | 186 | 69 | 4 | 5624b1fc7eab9f505588fcc86a24d14f8bcbfef7 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 186 | 69 | 4 | 4bb54043f944a979db91bde9a86dd66f498c7658 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.98e-04 | 186 | 69 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-04 | 187 | 69 | 4 | d69f4eee0304a7db226275ab77fc9d5d2b6f3a07 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-04 | 188 | 69 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 188 | 69 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | MS-Treg-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 2.11e-04 | 189 | 69 | 4 | b1310eed6113b3536868340a5b2b2587ad377fa9 | |
| ToppCell | MS-Treg|MS / Condition, Cell_class and T cell subcluster | 2.11e-04 | 189 | 69 | 4 | 3fa79242fb3dba4a3f52276da0124ba260423fb6 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.15e-04 | 190 | 69 | 4 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 190 | 69 | 4 | db19c72d8c8053262b535068c5a9d4d696989cb1 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-04 | 191 | 69 | 4 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.19e-04 | 191 | 69 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.24e-04 | 192 | 69 | 4 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.33e-04 | 194 | 69 | 4 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-04 | 195 | 69 | 4 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | severe-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.37e-04 | 195 | 69 | 4 | 73e39005a597e13aea571ae6ae5824d1c7448b71 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-04 | 196 | 69 | 4 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-04 | 197 | 69 | 4 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-04 | 197 | 69 | 4 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 198 | 69 | 4 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 198 | 69 | 4 | 5d57acbe0d245f8bd217eeea07af060092898fbd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.52e-04 | 198 | 69 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_activated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-04 | 199 | 69 | 4 | f4ab29f99ce45a3044d2e9f356dc24d3c5e7121f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.61e-04 | 200 | 69 | 4 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.99e-04 | 49 | 29 | 3 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | sulprostone | 2.12e-06 | 71 | 67 | 5 | CID005312153 | |
| Drug | AC1NY9KD | 3.95e-06 | 11 | 67 | 3 | CID005771741 | |
| Drug | AC1NIP3C | 6.39e-06 | 41 | 67 | 4 | CID004834553 | |
| Drug | Dinoprost Tromethamine | 8.53e-06 | 2 | 67 | 2 | DB01160 | |
| Drug | BMY 42393 | 1.08e-05 | 15 | 67 | 3 | CID000131961 | |
| Drug | AC1L1EKQ | 1.67e-05 | 52 | 67 | 4 | CID000002834 | |
| Drug | 8-iso Misoprostol | 3.36e-05 | 62 | 67 | 4 | CID004183806 | |
| Drug | iloprost | 4.72e-05 | 134 | 67 | 5 | CID005311181 | |
| Drug | 4-NA | 5.10e-05 | 4 | 67 | 2 | CID006102690 | |
| Drug | octimibate | 5.35e-05 | 25 | 67 | 3 | CID000065676 | |
| Drug | i-Pr | 6.40e-05 | 73 | 67 | 4 | CID000448400 | |
| Drug | SM-10906 | 6.77e-05 | 27 | 67 | 3 | CID006442261 | |
| Drug | Prostaglandin D2-d4 | 7.52e-05 | 240 | 67 | 6 | CID000004956 | |
| Drug | prenalterol | 7.57e-05 | 28 | 67 | 3 | CID000042396 | |
| Drug | Beraprost-d3 | 7.88e-05 | 77 | 67 | 4 | CID000002352 | |
| Drug | butaprost | 8.29e-05 | 78 | 67 | 4 | CID005311035 | |
| Drug | mitoxantrone | 9.14e-05 | 154 | 67 | 5 | CID000004212 | |
| Drug | AC1N2DGT | 9.34e-05 | 30 | 67 | 3 | CID004045015 | |
| Drug | AC1L1DXN | 1.21e-04 | 86 | 67 | 4 | CID000002552 | |
| Drug | AC1L1FGW | 1.25e-04 | 33 | 67 | 3 | CID000003231 | |
| Disease | height-adjusted body mass index | 1.39e-05 | 3 | 64 | 2 | EFO_0005851 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.46e-05 | 22 | 64 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | depressive symptom measurement, response to antidepressant | 4.09e-05 | 88 | 64 | 4 | EFO_0007006, GO_0036276 | |
| Disease | COVID-19, obesity | 9.66e-05 | 7 | 64 | 2 | EFO_0001073, MONDO_0100096 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.06e-04 | 10 | 64 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.06e-04 | 10 | 64 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.01e-04 | 12 | 64 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | waist circumference | 3.36e-04 | 429 | 64 | 6 | EFO_0004342 | |
| Disease | Connective Tissue Diseases | 3.56e-04 | 13 | 64 | 2 | C0009782 | |
| Disease | magnesium measurement | 4.04e-04 | 66 | 64 | 3 | EFO_0004845 | |
| Disease | Endometrioma | 4.20e-04 | 161 | 64 | 4 | C0269102 | |
| Disease | Endometriosis | 4.20e-04 | 161 | 64 | 4 | C0014175 | |
| Disease | Diabetic Angiopathies | 5.45e-04 | 16 | 64 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 5.45e-04 | 16 | 64 | 2 | C0025945 | |
| Disease | visceral adipose tissue measurement | 6.13e-04 | 481 | 64 | 6 | EFO_0004765 | |
| Disease | grip strength measurement | 9.81e-04 | 350 | 64 | 5 | EFO_0006941 | |
| Disease | unipolar depression | 1.13e-03 | 1206 | 64 | 9 | EFO_0003761 | |
| Disease | sex interaction measurement, body mass index, age at assessment | 1.14e-03 | 23 | 64 | 2 | EFO_0004340, EFO_0008007, EFO_0008343 | |
| Disease | susceptibility to pneumonia measurement | 1.24e-03 | 97 | 64 | 3 | EFO_0008410 | |
| Disease | osteoarthritis (is_implicated_in) | 1.69e-03 | 28 | 64 | 2 | DOID:8398 (is_implicated_in) | |
| Disease | mammographic density percentage | 1.81e-03 | 29 | 64 | 2 | EFO_0006502 | |
| Disease | Cocaine-Related Disorders | 2.12e-03 | 117 | 64 | 3 | C0236736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MTIQFSILIMLHSAL | 741 | P40145 | |
| LVLHSLTLMTNMQLN | 2721 | Q9NR09 | |
| LVMAQHMIRDIQTLL | 166 | P46379 | |
| VVNLVFLMVTLHKMI | 1016 | O94910 | |
| LQVMLTMHRIVISSA | 86 | O95267 | |
| ILSILHMIMSSVTLL | 1761 | Q5JWR5 | |
| LIQLDSMRLSHQMLV | 816 | Q96PN6 | |
| FMLSLQMLELITRLH | 836 | Q9UPY3 | |
| MILSIMDILNIKISH | 131 | P11836 | |
| TLMAEMHVVLLKAVL | 281 | Q12830 | |
| MIFLLLMLSLELQLH | 1 | Q9BQ51 | |
| LTHLIVQLDSDMIMS | 246 | Q8N130 | |
| VFIIMLMVQKLRHSL | 201 | Q7Z602 | |
| VILATHMQMEAILLD | 261 | Q9NXK6 | |
| MIIIMLTLSNIHLKT | 41 | A6NJZ3 | |
| MILIIRLDLQLHTPM | 46 | Q8N162 | |
| TANLVMILLIHMDSR | 41 | Q6IF00 | |
| AHQVLFMMLLATVLT | 21 | Q8NG77 | |
| QSMRLANLLMLLSHV | 451 | Q92731 | |
| TMHILVVHAMVILLT | 1161 | Q8N201 | |
| PQMLAHVRTLEMLSL | 166 | Q6UWE0 | |
| LLVMMSAITVALLSL | 16 | Q9NR71 | |
| MQKIMHISVLLSPVL | 1 | P42262 | |
| RSHHLEMVIQLLAIM | 241 | P43088 | |
| LVIILLMILDHRLHM | 41 | Q8NGZ2 | |
| AHQVLFMMVLSIVLT | 21 | A6NH00 | |
| LDLLKMQMSSLHNII | 1656 | Q96JB1 | |
| AHQVLFMMVLSIVLT | 21 | Q8NG76 | |
| TANLVMILLIHMDSR | 41 | Q8NGX2 | |
| LLTSLMHPNLQTLIM | 546 | Q9Y4D8 | |
| MMLLSAILTLLVTLV | 196 | A6NCV1 | |
| LSLMDLMHVSTIILK | 66 | Q8NHA4 | |
| AMIHSIEMINNSTLL | 76 | Q5T6X5 | |
| VMNCHLLILETFLMT | 296 | Q86UW1 | |
| VMSVLHEMLQQIFSL | 76 | P05000 | |
| ILMQLFRVLTNMTHE | 871 | Q5JSL3 | |
| TLVLAYLMIHKDMTL | 156 | Q68J44 | |
| VSHMVKLTLMLLVAG | 771 | O60266 | |
| EISIMTLRMFEHLLQ | 466 | Q5W0V3 | |
| LVDMTMHLNALNISL | 756 | Q86UP8 | |
| LVDMTMHLNALNISL | 756 | Q6EKJ0 | |
| QTLHKLEAMMLILQA | 2686 | P98161 | |
| IMIHILAGSTLMVSL | 196 | Q8NGG4 | |
| LIMFIVIQVGMALHT | 71 | Q8NGW6 | |
| SLLMNTIMLVVSILL | 191 | Q8NGT1 | |
| FIMATLMTLNTHSLL | 41 | P03901 | |
| LMRNSIFQLMIHTLD | 341 | Q9UI40 | |
| ILHLITMMALKVLGE | 321 | Q8NEK8 | |
| ENQALHPVIMALILM | 41 | A6NCI5 | |
| SRLMMEHVLLVSILH | 416 | Q5C9Z4 | |
| AIKILVHSLFSMLIM | 121 | Q9NY46 | |
| LLLLVTMIVNLAMTI | 41 | Q96LD1 | |
| MLMNLISRLVGIHEL | 316 | Q9NVU7 | |
| AIKILVHSLFSMLIM | 121 | P35498 | |
| ISCVFHQMLSVILML | 296 | P42695 | |
| LMEMQPILNTSLHRV | 421 | Q17RW2 | |
| TMYIALISLHALIMV | 176 | Q9NYG2 | |
| DHLILLALMTVVMAV | 236 | P43119 | |
| GLMQMLLLKVSAHIT | 146 | Q9H4I3 | |
| MHVEMILIFLCVLVI | 51 | Q8N4F7 | |
| ILNHMVSASMITLLL | 1931 | Q9H5I5 | |
| LITMAHMLQILLTVD | 1441 | Q8IWV7 | |
| SILASTLPQHMLQML | 231 | Q96DC7 | |
| MIILSHIYIIIMRLS | 1111 | Q7Z4N2 | |
| LRTMLITHMQDLQEV | 276 | Q15019 | |
| MTPQHMEALLQSLVI | 521 | Q08AF3 | |
| LTEEMLLKHLQRMVS | 206 | Q9NS93 | |
| VEMVCLHVISLMEAL | 2531 | Q9P2D8 | |
| HSTIVLTLLMSMFAL | 351 | Q96L42 | |
| IALMNALTVNLHLLM | 131 | Q16719 |